<prompt> A hirsuite lady with PCOD treatment is:Ethinyl estradiol LevonorgestrelEthinyl estradiol DesogestrelLevonorgestrelNone  <response>: Ans. is b, i.e. Ethinyl estradiol DesogestrelRef: Novak 14thed, p 1083, 15thed, p 1086 KDT Pharma 6thed, p 307OCPs decrease adrenal and ovarian androgen production and reduce hair growth in nearly two thirds of hirsute patients. When an OCP is used to treat hirsutism, a balance must be maintained between the decrease in free testosterone levels and the intrinsic androgenicity of the progestin.Progesterones with:High androgenic bioactivityNewer progestins with low androgenic bioactivity Norgestrel Desogestrel i.e. class III Norethindrone Gestodene Norethindrone acetate Norgestimate Drospirenone Thus, newer progestins with minimal androgenic activity are preferred for management of hirsutism in a patient of PCODPCOS i.e. option b is correct. 